Several possible studies
Story checked
Some Scientists Are Calling Alzheimer's 'Type 3 Diabetes' : ScienceAlert (opens in a new tab)
sciencealert.com · 2026-09-30
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Some Scientists Are Calling Alzheimer's 'Type 3 Diabetes' : ScienceAlert
sciencealert.com · 2026-09-30
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Source layer
The 6 papers the story cites
Source study separated from background citations.
The research anchor for the report.
- Points somewhere elsementioned without context
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?
Journal of Alzheimer's Disease · 2005
- Points somewhere elsementioned without context
Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease
International Journal of Molecular Sciences · 2020
- Cited as backgroundmentioned without context
Insulin and C-peptide in human brain neurons (insulin/C-peptide/brain peptides/immunohistochemistry/radioimmunoassay).
Journal Fur Hirnforschung · 1983
- Cited as backgroundmentioned without context
Hyperglycosylation is a metabolic driver of Alzheimer’s disease
Nature Metabolism · 2026
- Cited as backgroundmentioned without context
Rise in sugar decoration in Alzheimer’s disease
Nature Metabolism · 2026
- Cited as backgroundmentioned without context
A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer’s disease
Diabetology & Metabolic Syndrome · 2025
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 7Not checkedSome scientists have argued for over two decades that 'type 3 diabetes' is an apt label for some cases of Alzheimer's disease.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 7Not checkedThe article says emerging evidence suggests that in at least some cases, impaired insulin signaling in the brain may contribute to neurodegeneration and cognitive decline.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 7Not checkedIt states that poorly controlled blood sugar may increase the risk of developing Alzheimer's disease, and that impaired glucose or sugar metabolism is often one of the first changes detected in patients.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 7Not checkedThe article cites a 2020 study in mice reporting that insulin is made and released from several stress-sensing neurons in the hypothalamus, and that this region has the highest insulin levels in the human brain.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 7Not checkedIt reports a 2022 postmortem study at Cornell University finding 'massive' metabolic changes in brain tissue, including changes linked to cellular energy, glucose metabolism, inflammation and fatty acids.View evidenceHide evidence
As statedmassive
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 7Not checkedThe article says a study of three people who died with Alzheimer's found brain tissue with more 'sugar decorations' than healthy controls, which the article interprets as evidence of disrupted energy control possibly linked to insulin.View evidenceHide evidence
As statedthree patients
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 7 of 7Not checkedIt notes that a recent review argues type 3 diabetes is not a clinical diagnosis but a conceptual framework linking metabolic dysfunction with neurodegeneration, and that some researchers criticize the term as oversimplified and insufficiently proven.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
Crossref, PubMed, Europe PMC · 21 candidate papers
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?
Journal of Alzheimer's Disease · 2005 · Crossref
Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease
International Journal of Molecular Sciences · 2020 · Crossref
Insulin and C-peptide in human brain neurons (insulin/C-peptide/brain peptides/immunohistochemistry/radioimmunoassay).
Journal Fur Hirnforschung · 1983 · PubMed
Hyperglycosylation is a metabolic driver of Alzheimer’s disease
Nature Metabolism · 2026 · Crossref
Rise in sugar decoration in Alzheimer’s disease
Nature Metabolism · 2026 · Crossref
And 16 more candidates considered.